Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $10.00 at Stifel Nicolaus
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its target price boosted by Stifel Nicolaus from $8.00 to $10.00 in a research note issued to investors...
Benchmark Reiterates Buy Rating for VSE (NASDAQ:VSEC)
Benchmark reissued their buy rating on shares of VSE (NASDAQ:VSEC – Free Report) in a report issued on Monday, Benzinga reports. The brokerage currently has...
Capital One Financial Begins Coverage on Atlassian (NASDAQ:TEAM)
Capital One Financial started coverage on shares of Atlassian (NASDAQ:TEAM – Free Report) in a report published on Monday, Briefing.com reports. The firm issued an...
Democrat 2024 Candidate Says Colorado Court ‘Wrong’ to Bar Trump From Ballot
By Ryan Morgan A Democratic congressman and 2024 presidential candidate has denounced the Colorado Supreme Court’s decision this week to order former President Donald Trump...
Inflation Pushes Public Debt Interest to New November Record
By Lily Zhou The UK has spent £7.7 billion on servicing central government debt in November, the highest for the month on record, according to...
Adults Decline New COVID-19 Shots: CDC Studies
By Zachary Stieber Few older adults are taking the recently cleared respiratory syncytial virus vaccines, according to new studies from the U.S. Centers for Disease...